Sullivan Christopher Ryan
CIK 1810417
Transactions on file
14
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 2026-05-21 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Grant | 39,900 | $0.00 | — | open → |
| 2026-05-11 | 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 18,606 | $448.8K | -46.5% | open → |
| 2026-05-11 | 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 18,606 | $183.8K | +30.6% | open → |
| 2025-04-01 | 2025-03-28 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 24,200 | — | — | open → |
| 2025-04-01 | 2025-03-28 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Tax | 7,285 | $61.6K | +52.5% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,900 | $200.9K | -42.9% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 9,219 | $197.0K | -39.6% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 2,700 | $56.1K | -37.9% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 12,347 | $238.1K | -33.1% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 13,834 | $256.7K | -30.5% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 47,000 | $377.9K | +60.4% | open → |
| 2026-05-01 | 2026-04-30 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,457 | $111.9K | -2.5% | open → |
| 2026-05-01 | 2026-04-29 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,458 | $110.7K | -1.5% | open → |
| 2025-12-12 | 2025-12-10 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Tax | 155 | $635.50 | +214.6% | open → |
